Un estudio revela que una única neurona de la corteza cerebral humana posee una capacidad computacional comparable a la de ...
Neurona Therapeutics, a San Francisco-based biotechnology company, has raised another $120 million to fuel its research into cell therapies for brain diseases. Neurona plans to use the money to ...
SOUTH SAN FRANCISCO, CA--(Marketwired - December 01, 2015) - Neurona Therapeutics Inc., a biotechnology company focused on the transplantation of selected neurons to treat intractable neurological ...
Neurona Therapeutics Inc., a biotechnology company focused on the transplantation of selected neurons to treat intractable neurological diseases, today announced its launch with a $23.5 million Series ...
SAN FRANCISCO, July 11, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today ...
Belgian pharma company UCB (UCBJY) on Friday announced an agreement to acquire Neurona Therapeutics, a U.S.-based developer of cell therapies for neuronal diseases, for a total consideration of up to ...
Hosted on MSN
UCB to purchase Neurona and NRTX-1001 for $1.15bn
UCB has signed a definitive agreement to acquire Neurona Therapeutics in a deal worth up to $1.15bn, adding the latter’s lead asset NRTX-1001 to its epilepsy portfolio. The deal value comprises an ...
SAN FRANCISCO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage, privately-held, biotherapeutics company advancing regenerative cell therapies for disorders of the nervous ...
Please provide your email address to receive an email when new articles are posted on . Neurona Therapeutics has announced that a phase 1/2 clinical trial for NRTX-1001, a regenerative neural cell ...
NRTX-1001 is being assessed for drug-resistant mesial temporal lobe epilepsy Neurona Therapeutics has announced that it has secured $120m in funding to help advance its lead candidate, NRTX-1001, a ...
SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, ...
Company Combines Leaders in Fields of Neuroscience and Stem Cell Biology to Develop Cell Therapies With Broad Potential to Treat Neurological Disease SOUTH SAN FRANCISCO, CA--Neurona Therapeutics Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results